![Steven Glauser](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 300 701 $ au 31/07/2026
Mr. Steven J.
Glauser is an Independent Non-Executive Director at ZEO ScientifiX, Inc. He is on the Board of Directors at ZEO ScientifiX, Inc. and National Jewish Health, Inc. Mr. Glauser was previously employed as a Principal by Sorrento Therapeutics, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZEO SCIENTIFIX INC. 3,3 % | 28/01/2026 | 258 334 ( 3,3 % ) | 300 701 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ORGANICELL REGENERATIVE MEDICINE INC | Directeur/Membre du Conseil | 23/09/2022 |
National Jewish Health, Inc.
 National Jewish Health, Inc. Medical/Nursing ServicesHealth Services Provides treatment of and conducts research in respiratory, immune and allergic disorders | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
ZEO ScientifiX, Inc.
 ZEO ScientifiX, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops biological therapeutics for the treatment of degenerative diseases | Health Technology |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
National Jewish Health, Inc.
National Jewish Health, Inc. Medical/Nursing ServicesHealth Services Provides treatment of and conducts research in respiratory, immune and allergic disorders | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
